D.A. Davidson & CO. Decreases Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

D.A. Davidson & CO. decreased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 3.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,534 shares of the real estate investment trust’s stock after selling 909 shares during the quarter. D.A. Davidson & CO.’s holdings in Omega Healthcare Investors were worth $917,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. FMR LLC boosted its stake in Omega Healthcare Investors by 9.9% during the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after buying an additional 380,626 shares during the period. Bank of Montreal Can lifted its holdings in shares of Omega Healthcare Investors by 309.7% in the 3rd quarter. Bank of Montreal Can now owns 267,394 shares of the real estate investment trust’s stock worth $10,784,000 after acquiring an additional 202,131 shares during the last quarter. Truvestments Capital LLC purchased a new position in shares of Omega Healthcare Investors during the 3rd quarter worth about $43,000. Loomis Sayles & Co. L P purchased a new stake in Omega Healthcare Investors in the 3rd quarter worth about $47,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Omega Healthcare Investors in the third quarter worth about $299,000. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Down 0.1 %

NYSE OHI opened at $40.61 on Monday. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The company has a market capitalization of $10.96 billion, a price-to-earnings ratio of 29.86, a price-to-earnings-growth ratio of 1.26 and a beta of 0.99. The company’s 50-day simple moving average is $40.61 and its two-hundred day simple moving average is $37.40.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.60%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s payout ratio is 197.06%.

Insider Buying and Selling

In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This trade represents a 10.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on OHI shares. BMO Capital Markets upped their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Scotiabank increased their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Berenberg Bank assumed coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 target price for the company. BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.